Disparities in insurance status negatively affect patients with infantile hypertrophic pyloric stenosis

Daniel A Reich1, Genesys Giraldo2, William Canty2

  • 1College of Medicine, University of Florida, 1142 SW 9th Rd. Unit 401, Gainesville, FL, 32601, USA. Daniel.reich@ufl.edu.

Insights

Social determinants of health impact infantile hypertrophic pyloric stenosis (IHPS) care. Medicaid Managed Care (MMC) may improve access to care for infants with IHPS, leading to earlier diagnosis and treatment.

Area of Science:

  • Pediatric Surgery
  • Public Health
  • Health Services Research

Background:

  • Infantile hypertrophic pyloric stenosis (IHPS) is a common surgical condition in infants.
  • Prolonged illness duration before presentation is associated with worse IHPS outcomes.
  • Social determinants of health (SDOH) may influence healthcare access and outcomes for IHPS patients.

Purpose of the Study:

  • To evaluate how SDOH influence medical care and outcomes for infants with IHPS.
  • To assess the impact of Medicaid Managed Care (MMC) on IHPS patient care and outcomes.

Main Methods:

  • Retrospective review of 279 IHPS cases over 10 years.
  • Used census data (Geo-Identification codes) as a proxy for socioeconomic status.
  • Correlated food access and social vulnerability variables with IHPS presentation and outcomes.
  • Subdivided cohort to analyze the impact of phased MMC implementation.

Main Results:

  • Infants presenting after phased MMC implementation were older at presentation (41.5 vs. 36.5 days) and had a longer symptomatic course (12.8 vs. 8.9 days).
  • No significant differences observed in race, gender, or length of stay between groups.
  • Infants with public insurance post-MMC were more likely to have timely outpatient pediatric follow-up (within 1 month).

Conclusions:

  • Phased MMC implementation was associated with older presentation age and longer symptomatic duration for IHPS.
  • Despite delays, MMC may have improved outpatient follow-up rates for publicly insured infants with IHPS.
  • SDOH, particularly through insurance models like MMC, play a crucial role in IHPS care delivery and outcomes.
Abstract

Related Concept Videos

Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
86
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
67
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
164
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
382
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
297
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
113